Trends in CD4 Counts in HIV Patients on Antiretroviral Treatment
Author Information
Author(s): Zhou Jialun, Sirisanthana Thira, Kiertiburanakul Sasisopin, Chen Yi-Ming, Han Ning, Lim Poh_Lian, Kumarasamy Nagalingeswaran, Choi Jun Yong, Merati Tuti Parwati, Yunihastuti Evy, Oka Shinichi, Kamarulzaman Adeeba, Phanuphak Praphan, Lee Christopher KC, Li Patrick CK, Pujari Sanjay, Saphonn Vanthanak, Law Matthew G
Primary Institution: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
Hypothesis
The study aims to examine the relationship between trends in CD4 counts and HIV viral load after initiation of combination antiretroviral treatment in Asian patients.
Conclusion
CD4 counts continued to increase after starting treatment, even with detectable HIV viral load, but needed to be controlled at lower levels to maintain a positive CD4 count slope over time.
Supporting Evidence
- The median time on combination antiretroviral treatment was 4.2 years.
- CD4 count slope was associated with age, concurrent HIV viral load, and disease stage.
- CD4 counts continued to increase with HIV viral load up to 20,000 copies/mL during the first 6-12 months after treatment initiation.
Takeaway
This study shows that HIV patients can still improve their immune health even if the virus is detectable, but they need to keep the virus levels low to keep getting better.
Methodology
The study included treatment-naive HIV-infected patients who started combination antiretroviral treatment and had multiple CD4 count and HIV viral load tests, analyzing data using random-effects linear regression models.
Potential Biases
The study may be biased due to the urban referral center setting and the selection of patients considered to have a good prospect for long-term follow-up.
Limitations
The study's patient population may not represent all HIV-infected individuals in the Asia-Pacific region, and there is a lack of data on treatment adherence and survival outcomes.
Participant Demographics
The median age of participants was 36 years, with 74% male and 12% having hepatitis B or C co-infection.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website